fbpx
  • Panels
    • ePlex Panels
      • Respiratory
      • Blood Culture
    • XT-8 Panels
  • Systems
    • ePlex System
      • Software Solutions
      • Patient Safety
    • XT-8 System
  • Company
    • The GenMark Story
      • Management Team
      • Board of Directors
    • Careers
      • Opportunities
    • Investors
    • Newsroom
  • Education
    • Disease State
      • Sepsis
      • Respiratory Infections
      • Genetic Conditions
      • Hepatitis C
      • GI Infections
    • Technology
    • Resources
  • Support
    • Contact Us
    • FAQs
    • Safety Data Sheets (SDS)
    • Your Long-Term Partner
SELECT YOUR REGION:
  • International
    • United States
| CONTACT US | CUSTOMER RESOURCE CENTER
GenMark
  • Panels
    • ePlex Panels
      • Respiratory Pathogen Panels
      • Blood Culture
  • Systems
    • ePlex System
      • Software Solutions
      • Patient Safety
  • Company
    • The GenMark Story
      • Management Team
      • Board of Directors
    • Careers
      • Opportunities
    • Investors
    • Newsroom
  • Education
    • Disease State
      • Sepsis
      • Respiratory Infections
      • GI Infections
    • Technology
    • Resources
  • Support
    • Contact Us
    • FAQs
    • Safety Data Sheets (SDS)
    • Long-Term Partner

Detection of variant SARS-CoV-2 strains on the ePlex® RP2 Panel*

February 9, 2021

Genetic surveillance of SARS-CoV-2 strains circulating globally has identified multiple variants containing one or more mutations that can potentially impact detection by nucleic acid based testing methods. These variants can also impact behavior of the virus, such as making a virus more or less transmissible or capable of causing more severe illness. Health organizations around the world are closely monitoring the circulation of these known variants and are also working to identify any additional variants that arise.

 

The ePlex Respiratory Pathogen Panel 2 (RP2 Panel) targets 2 unique regions of the N (nucleoprotein) gene. The GenMark bioinformatics team performs regular sequence analysis of available SARS-CoV-2 strains to review new mutations and to determine if these variants affect the performance of the ePlex RP2 Panel SARS-CoV-2 assays.

 

The table below summarizes SARS-CoV-2 variant strains identified to date and the impact, if any, on the ePlex RP2 Panel based on bioinformatic analysis.1-7 This list will be updated as new strain information becomes available. This list is not intended to be a comprehensive list of all variants or mutations identified; it includes the most prevalent variants in circulation and mutations that are believed to be clinically significant. Based on analysis of currently available sequence information, the variants shown on the table do not include mutations that would impact the performance of the ePlex RP2 Panel SARS-CoV-2 assays and these strains will be detected as expected.

SARS-CoV-2 Variant

Also
Known As

First Detected

Common Mutations

Impact to ePlex RP2 Panel

B.1.1.7

20I/501Y.V1
VOC 202012/01
GR/501.V1

United Kingdom

23 mutations including:
N501Y (spike protein)
69/70 deletion (spike protein)
P681H (spike protein)
D3L (nucleoprotein)
S235F (nucleoprotein)

No impact

B.1.351

20H/501Y.V2
GH/501.V2

South Africa

K417N (spike protein)
E484K (spike protein)
N501Y (spike protein)

No impact

P.1

B.1.1.28
20J/501Y.V3
GR/484K.V2

Japan/Brazil

K417T (spike protein)
E484K (spike protein)
N501Y (spike protein)

No impact

COH.20G/501Y

N/A

Ohio, USA

N501Y (spike protein)
Q677H (membrane glycoprotein)
D377Y (Nucleoprotein)

No impact

B.1.429

CAL.20C
GH/452R.V1

California, USA

L452R (spike protein)

No impact

*For use under the Emergency Use Authorization (EUA) only. For in vitro diagnostic use.

 

1. Centers for Disease Control and Prevention.  Emerging SARS-CoV-2 Variants.  https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/scientific-brief-emerging-variants.html (accessed January 2021)
2. European Centre for Disease Prevention and Control. January 21, 2021. Risk Related to Spread of New SARS-CoV-2 Variants of Concern in the EU/EEA- first update.
3. Zimmer, K. January 26, 221.  A guide to emerging SARS-CoV-2 variants.  The Scientist.  https://www.the-scientist.com/news-opinion/a-guide-to-emerging-sars-cov-2-variants-68387
4. Jones, A.  January 2021.  Coronavirus variant linked to COIVD-19 outbreaks in California.  The Scientist. https://www.the-scientist.com/news-opinion/coronavirus-variant-linked-to-covid-19-outbreaks-in-california-68365
5. Tu, H. et al. (2021) Distinct patterns of emergence of SARS-CoV-2 spike variants including N501Y in clinical samples in Columbus Ohio.  bioRxiv 2021.01.12.426407; doi: https://doi.org/10.1101/2021.01.12.426407
6. Zimmer, C. January 19, 2021.  New California variant may be driving virus surge there, study suggests.  New York Times.  https://www.nytimes.com/2021/01/19/health/coronavirus-variant-california.html
7. Centers for Disease Control and Prevention. SARS-CoV-2 Variants. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/variant-surveillance/variant-info.html (accessed February 2021)

GenMark Diagnostics, Inc.
5964 La Place Court
Carlsbad, CA 92008

 

© Copyright 2021 GenMark Diagnostics, Inc.
All rights reserved.

 

info@genmarkdx.com
P: +1 760-448-4300
F: +1 760-448-4301

 

Legal | Privacy Policy

 

 

This website uses cookies to improve your experience. Read More. You can opt-out if you wish. Change settingsACCEPT REJECT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

Popup Button